Technical Analysis for ACST - Acasti Pharma, Inc.

Grade Last Price % Change Price Change
D 0.834 13.02% 0.10
ACST closed up 13.02 percent on Wednesday, February 24, 2021, on 60 percent of normal volume.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Strong Up Up Down
Historical ACST trend table...

Date Alert Name Type % Chg
20 DMA Resistance Bearish 0.00%
New Uptrend Bullish 0.00%
Wide Bands Range Expansion 0.00%
New Downtrend Bearish 13.02%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 13.02%
Wide Bands Range Expansion 13.02%
Gapped Down Weakness 13.02%
Fell Below 20 DMA Bearish -0.48%
1,2,3 Pullback Bullish Bullish Swing Setup -0.48%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup -0.48%
Older End-of-Day Signals for ACST ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
20 DMA Resistance about 18 hours ago
Rose Above 20 DMA about 18 hours ago
60 Minute Opening Range Breakout about 18 hours ago
Up 1 ATR about 18 hours ago
Non-ADX 1,2,3,4 Pullback Entry about 20 hours ago
View Earlier Intraday Alerts

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Acasti Pharma Inc., a biopharmaceutical company, focuses on the research, development, and commercialization of new therapies for abnormalities in blood lipids, and the treatment and prevention of cardiovascular disorders. The company offers Onemia, a medical food that is used in the dietary management of illnesses associated with omega-3 phospholipids deficiency related to cardiometabolic disorders. Its product development pipeline includes CaPre, a drug product candidate that is in Phase II clinical trial for the prevention and treatment of cardiometabolic disorders, including hypertriglyceridemia. The company was incorporated in 2002 and is headquartered in Laval, Canada. Acasti Pharma Inc. is a subsidiary of Neptune Technologies & Bioressources Inc.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biopharmaceutical Cardiovascular Disease Lipid Drug Product Metabolic Disorders Fatty Acids Lipids Triglyceride Medical Food Cardiovascular Disorders Hypertriglyceridemia Omega 3 Fatty Acid Onemia

Is ACST a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 1.22
52 Week Low 0.171
Average Volume 59,972,193
200-Day Moving Average 0.51
50-Day Moving Average 0.63
20-Day Moving Average 0.86
10-Day Moving Average 0.97
Average True Range 0.13
ADX 46.32
+DI 33.55
-DI 27.05
Chandelier Exit (Long, 3 ATRs ) 0.83
Chandelier Exit (Short, 3 ATRs ) 0.96
Upper Bollinger Band 1.19
Lower Bollinger Band 0.53
Percent B (%b) 0.46
BandWidth 76.73
MACD Line 0.07
MACD Signal Line 0.10
MACD Histogram -0.0341
Fundamentals Value
Market Cap 80.81 Million
Num Shares 96.9 Million
EPS -1.22
Price-to-Earnings (P/E) Ratio -0.68
Price-to-Sales 0.00
Price-to-Book 3.71
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 1.04
Resistance 3 (R3) 1.04 0.97 1.01
Resistance 2 (R2) 0.97 0.92 0.97 1.00
Resistance 1 (R1) 0.90 0.89 0.94 0.90 0.98
Pivot Point 0.83 0.83 0.85 0.83 0.83
Support 1 (S1) 0.77 0.78 0.80 0.76 0.68
Support 2 (S2) 0.70 0.75 0.70 0.67
Support 3 (S3) 0.63 0.70 0.66
Support 4 (S4) 0.63